Cresco Labs Inc. (FRA:6CQ)

Germany flag Germany · Delayed Price · Currency is EUR
0.663
-0.026 (-3.70%)
Last updated: Dec 4, 2025, 3:43 PM CET
-36.80%
Market Cap 245.64M
Revenue (ttm) 563.90M
Net Income (ttm) -44.48M
Shares Out n/a
EPS (ttm) -0.13
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 87
Open 0.661
Previous Close 0.689
Day's Range 0.661 - 0.663
52-Week Range 0.364 - 1.256
Beta n/a
RSI 40.41
Earnings Date Mar 12, 2026

About Cresco Labs

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company offers canna... [Read more]

Industry Pharmaceutical Preparations
CEO Charles Bachtell
Employees 2,900
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 6CQ
Full Company Profile

Financial Performance

In 2024, Cresco Labs's revenue was $715.76 million, a decrease of -5.33% compared to the previous year's $756.06 million. Losses were -$74.44 million, -57.59% less than in 2023.

Financial numbers in USD Financial Statements

News

There is no news available yet.